The global impact of COVID-19 distracted us from the global issues of pharmaceutical manufacturing. Our safety is at risk, when foreign countries deny access to the FDA to ensure safe manufacturing practices and yet we find ourselves dependent on those countries for strategic advanced pharmaceutical ingredients. Rosemary Gibson sounded the alarm with her best selling book, China Rx.  She spoke at ASCP's 2019 annual meeting and she is back today to discuss what strides we have made to improve safety and bring back some capacity to make important medications in the United States. 

Ver todos los episodios